Enhancing the fisetin efficacy through encapsulation with polymannose and nanotization for effective anticancer therapy towards breast cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Flavonoids in Medical Research · Natural product bioactivities and synthesis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Gim S, Zhu Y, Seeberger PH, Delbianco M (2019) Carbohydrate-based nanomaterials for biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 11(5):e1558. https://doi.org/10.1002/wnan.155810.1002/wnan.1558 ↗
2. Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK (2019) Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg 6(1):1–30. https://doi.org/10.1186/s40580-019-0193-210.1186/s40580-019-0193-2 ↗
3. Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine 12:7291–7309. https://doi.org/10.2147/IJN.S14631510.2147/IJN.S146315 ↗
4. Kashyap D, Sharma A, Sak K, Tuli HS, Buttar HS, Bishayee A (2018) Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci 194:75–87. https://doi.org/10.1016/j.lfs.2017.12.00510.1016/j.lfs.2017.12.005 ↗
5. Pal HC, Pearlman RL, Afaq F (2016) Fisetin and its role in chronic diseases. Adv Exp Med Biol 928:213–244. https://doi.org/10.1007/978-3-319-41334-1_1010.1007/978-3-319-41334-1_10 ↗
6. Inkielewicz-Stepniak I, Radomski MW, Wozniak M (2012) Fisetin prevents fluoride- and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells. Food Chem Toxicol 50(3-4):583–589. https://doi.org/10.1016/j.fct.2011.12.01510.1016/j.fct.2011.12.015 ↗
7. Li J, Gong X, Jiang R, Lin D, Zhou T, Zhang A, Li H, Zhang X, Wan J, Kuang G, Li H (2018) Fisetin inhibited growth and metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via PTEN/Akt/GSK3β signal pathway. Front Pharmacol 9:772. https://doi.org/10.3389/fphar.2018.0077210.3389/fphar.2018.00772 ↗
8. Guo G, Zhang W, Dang M, Yan M, Chen Z (2019) Fisetin induces apoptosis in breast cancer MDA-MB-453 cells through degradation of HER2/neu and via the PI3K/Akt pathway. J Biochem Mol Toxicol 33(4):e22268. https://doi.org/10.1002/jbt.2226810.1002/jbt.22268 ↗
9. Tsai CF, Chen JH, Chang CN, Lu DY, Chang PC, Wang SL, Yeh WL (2018) Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. Food Chem Toxicol 120:528–535. https://doi.org/10.1016/j.fct.2018.07.05910.1016/j.fct.2018.07.059 ↗
10. Mignet N, Seguin J, Ramos Romano M, Brullé L, Touil YS, Scherman D, Bessodes M, Chabot GG (2012) Development of a liposomal formulation of the natural flavonoid fisetin. Int J Pharm 423(1):69–76. https://doi.org/10.1016/j.ijpharm.2011.04.06610.1016/j.ijpharm.2011.04.066 ↗
11. Kulbacka J, Pucek A, Kotulska M, Dubińska-Magiera M, Rossowska J, Rols MP, Wilk KA (2016) Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer. Bioelectrochemistry (Amsterdam, Netherlands) 110:19–31. https://doi.org/10.1016/j.bioelechem.2016.02.01310.1016/j.bioelechem.2016.02.013 ↗
12. Chavda VP, Patel AB, Mistry KJ, Suthar SF, Wu ZX, Chen ZS, Hou K (2022) Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges. Front Oncol 12:867655. https://doi.org/10.3389/fonc.2022.86765510.3389/fonc.2022.867655 ↗
13. Sufi SA, Hoda M, Pajaniradje S, Mukherjee V, Coumar SM, Rajagopalan R (2020) Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480. Int J Pharm 588:119738. https://doi.org/10.1016/j.ijpharm.2020.11973810.1016/j.ijpharm.2020.119738 ↗
14. Sood A, Gupta A, Agrawal G (2021) Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications. Carbohydr Polym Technol Appl 2:100067. https://doi.org/10.1016/j.carpta.2021.10006710.1016/j.carpta.2021.100067 ↗
15. Francis AP, Jayakrishnan A (2019) Conjugating doxorubicin to polymannose: a new strategy for target specific delivery to lung cancer cells. J Biomater Sci Polym Ed 30(16):1471–1488. https://doi.org/10.1080/09205063.2019.164647510.1080/09205063.2019.1646475 ↗
16. Francis AP, Gurudevan S, Jayakrishnan A (2018) Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates. J Biomater Sci Polym Ed 29(13):1529–1548. https://doi.org/10.1080/09205063.2018.146918610.1080/09205063.2018.1469186 ↗
17. Kakran M, Sahoo NG, Tan IL, Li L (2012) Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods. J Nanopart Res. https://doi.org/10.1007/s11051-012-0757-010.1007/s11051-012-0757-0 ↗
18. Sebak S, Mirzaei M, Malhotra M, Kulamarva A, Prakash S (2010) Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int J Nanomedicine 5:525–532. https://doi.org/10.2147/ijn.s1044310.2147/ijn.s10443 ↗
19. Dzakwan M, Pramukantoro GE, Mauludin R, Wikarsa S (2016) Formulation and characterization of fisetin nanosuspension. IOP Conf Ser Mater Sci Eng 259. https://doi.org/10.1088/1757-899X/259/1/01201610.1088/1757-899X/259/1/012016 ↗
20. Weinbuch D, Cheung JK, Ketelaars J, Filipe V, Hawe A, den Engelsman J, Jiskoot W (2015) Nanoparticulate impurities in pharmaceutical-grade sugars and their interference with light scattering-based analysis of protein formulations. Pharm Res 32(7):2419–2427. https://doi.org/10.1007/s11095-015-1634-110.1007/s11095-015-1634-1 ↗
21. Ghosh P, Singha Roy A, Chaudhury S, Jana SK, Chaudhury K, Dasgupta S (2016) Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. Int J Biol Macromol 86:408–417. https://doi.org/10.1016/j.ijbiomac.2016.01.08210.1016/j.ijbiomac.2016.01.082 ↗
22. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67(3):217–223
23. Arjunan A, Pajaniradje S, Francis AP, Subramanian S, Chandramohan S, Parthasarathi D, Sajith AM, Padusha MSA, Mathur PP, Rajagopalan R (2021) Epigenetic modulation and apoptotic induction by a novel imidazo-benzamide derivative in human lung adenocarcinoma cells. Daru, J Fac Pharm, Tehran Univ Med Sci 29(2):377–387. https://doi.org/10.1007/s40199-021-00419-310.1007/s40199-021-00419-3 ↗
24. Hoda M, Pajaniradje S, Shakya G, Mohankumar K, Rajagopalan R (2016) Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line. Nanomedicine 12(6):1641–1650. https://doi.org/10.1016/j.nano.2016.02.01310.1016/j.nano.2016.02.013 ↗
25. Pajaniradje S, Mohankumar K, Pamidimukkala R, Subramanian S, Rajagopalan R (2014) Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells. Biomed Res Int:474953. https://doi.org/10.1155/2014/47495310.1155/2014/474953 ↗
26. Mohankumar K, Pajaniradje S, Sridharan S, Singh VK, Ronsard L, Banerjea AC, Selvanesan BC, Coumar MS, Periyasamy L, Rajagopalan R (2014) Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways. Cell Oncol (Dordr) 37(6):439–454. https://doi.org/10.1007/s13402-014-0207-310.1007/s13402-014-0207-3 ↗
27. Mohankumar K, Pajaniradje S, Sridharan S, Singh VK, Ronsard L, Banerjea AC, Benson CS, Coumar MS, Rajagopalan R (2014) Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin--an in vitro and in silico approach. Chem Biol Interact 210:51–63. https://doi.org/10.1016/j.cbi.2013.12.00610.1016/j.cbi.2013.12.006 ↗
28. Mohankumar K, Francis AP, Pajaniradje S, Rajagopalan R (2021) Synthetic curcumin analog: inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway. Mol Biol Rep 48(8):6065–6074. https://doi.org/10.1007/s11033-021-06610-810.1007/s11033-021-06610-8 ↗
29. Teng Z, Luo Y, Wang Q (2012) Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation. J Agric Food Chem 60(10):2712–2720. https://doi.org/10.1021/jf205238x10.1021/jf205238x ↗
30. Chen L, Xu P, Fu C, Kankala RK, Chen A, Wang S (2020) Fabrication of supercritical antisolvent (SAS) process-assisted fisetin-encapsulated poly (vinyl pyrrolidone) (PVP) nanocomposites for improved anticancer therapy. Nanomaterials 10(2):322. https://doi.org/10.3390/nano1002032210.3390/nano10020322 ↗
31. Subramanian SB, Francis AP, Devasena T (2014) Chitosan-starch nanocomposite particles as a drug carrier for the delivery of bis-desmethoxy curcumin analog. Carbohydr Polym 114:170–178. https://doi.org/10.1016/j.carbpol.2014.07.05310.1016/j.carbpol.2014.07.053 ↗
32. Chellampillai B, Pawar AP (2011) Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles. Eur J Drug Metab Pharmacokinet 35(3-4):123–129. https://doi.org/10.1007/s13318-010-0016-710.1007/s13318-010-0016-7 ↗
33. Juurlink DN (2020) Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Can Med Assoc J 192(17):E450–E453. https://doi.org/10.1503/cmaj.20052810.1503/cmaj.200528 ↗
34. Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11(6):673–692. https://doi.org/10.2217/nnm.16.510.2217/nnm.16.5 ↗
35. Francis AP, Ramaprabhu S, Devasena T (2016) Towards intravenous drug delivery: augmenting the stability and dispersity of bis-demethoxy curcumin analog by bottom-up strategy. J Nanosci Nanotechnol 16(1):1186–1189. https://doi.org/10.1166/jnn.2016.1234410.1166/jnn.2016.12344 ↗
36. Pokharkar VB, Mandpe LP, Padamwar MN, Ambike AA, Mahadik KR, Paradkar A (2006) Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol 167:20–25. https://doi.org/10.1016/j.powtec.2006.05.01210.1016/j.powtec.2006.05.012 ↗
37. Lu X, Jung JI, Cho HJ, Lim DY, Lee HS, Chun HS, Kwon DY, Park JH (2005) Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr 135(12):2884–2890. https://doi.org/10.1093/jn/135.12.288410.1093/jn/135.12.2884 ↗
38. Dalle Vedove E, Costabile G, Merkel OM (2018) Mannose and Mannose-6-phosphate receptor-targeted drug delivery systems and their application in cancer therapy. Adv Healthc Mater 7(14):e1701398. https://doi.org/10.1002/adhm.20170139810.1002/adhm.201701398 ↗
39. Xiao X, Zou J, Fang Y, Meng Y, Xiao C, Fu J, Liu S, Bai P, Yao Y (2018) Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells. BMC Complement Altern Med 18(1):91. https://doi.org/10.1186/s12906-018-2127-710.1186/s12906-018-2127-7 ↗
40. Atale N, Gupta S, Yadav UC, Rani V (2014) Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques. J Microsc 255(1):7–19. https://doi.org/10.1111/jmi.1213310.1111/jmi.12133 ↗
41. Matés JM, Segura JA, Alonso FJ, Márquez J (2012) Oxidative stress in apoptosis and cancer: an update. Arch Toxicol 86(11):1649–1665. https://doi.org/10.1007/s00204-012-0906-310.1007/s00204-012-0906-3 ↗
42. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G (2006) Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 13(9):1423–1433. https://doi.org/10.1038/sj.cdd.440195010.1038/sj.cdd.4401950 ↗